These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 30676494)

  • 1. Propensity-score-adjusted comparison of Evolut vs. Portico devices for transcatheter aortic valve implantation.
    Giordano A; Corcione N; Ferraro P; Pieri P; Avellino R; Frati G; De Persio G; Altamura L; Tomai F; Biondi-Zoccai G
    J Cardiovasc Med (Hagerstown); 2019 May; 20(5):351-357. PubMed ID: 30676494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-Term Follow-Up of Transcatheter Aortic Valve Implantation With Portico Versus Evolut Devices.
    Corcione N; Biondi-Zoccai G; Ferraro P; Morello A; Conte S; Cimmino M; Vigna C; Frati G; De Persio G; Altamura L; Tomai F; Berni A; Cassese M; Pepe M; Giordano A
    Am J Cardiol; 2020 Apr; 125(8):1209-1215. PubMed ID: 32087996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcatheter Self-Expandable Valve Implantation for Aortic Stenosis in Small Aortic Annuli: The TAVI-SMALL Registry.
    Regazzoli D; Chiarito M; Cannata F; Pagnesi M; Miura M; Ziviello F; Picci A; Reifart J; De Marco F; Bedogni F; Adamo M; Curello S; Teles R; Taramasso M; Barbanti M; Tamburino C; Stefanini GG; Mangieri A; Giannini F; Pagnotta PA; Maisano F; Kim WK; Van Mieghem NM; Colombo A; Reimers B; Latib A;
    JACC Cardiovasc Interv; 2020 Jan; 13(2):196-206. PubMed ID: 31883714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Predilation Before Transcatheter Aortic Valve Implantation with New-Generation Devices.
    Giordano A; Corcione N; Ferraro P; Morello A; Conte S; Bedogni F; Testa L; Iadanza A; Sardella G; Mancone M; Tomai F; De Persio G; Attisano T; Pepe M; Frati G; Biondi-Zoccai G;
    Cardiovasc Revasc Med; 2019 Dec; 20(12):1096-1099. PubMed ID: 30711476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter Aortic Valve Replacement With Next-Generation Self-Expanding Devices: A Multicenter, Retrospective, Propensity-Matched Comparison of Evolut PRO Versus Acurate neo Transcatheter Heart Valves.
    Pagnesi M; Kim WK; Conradi L; Barbanti M; Stefanini GG; Zeus T; Pilgrim T; Schofer J; Zweiker D; Testa L; Taramasso M; Hildick-Smith D; Abizaid A; Wolf A; Van Mieghem NM; Sedaghat A; Wöhrle J; Khogali S; Van der Heyden JAS; Webb JG; Estévez-Loureiro R; Mylotte D; MacCarthy P; Brugaletta S; Hamm CW; Bhadra OD; Schäfer U; Costa G; Tamburino C; Cannata F; Reimers B; Veulemans V; Asami M; Windecker S; Eitan A; Schmidt A; Bianchi G; Bedogni F; Saccocci M; Maisano F; Alsanjari O; Siqueira D; Jensen CJ; Naber CK; Ziviello F; Sinning JM; Seeger J; Rottbauer W; Brouwer J; Alenezi A; Wood DA; Tzalamouras V; Regueiro A; Colombo A; Latib A
    JACC Cardiovasc Interv; 2019 Mar; 12(5):433-443. PubMed ID: 30846081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial Experience of a Second-Generation Self-Expanding Transcatheter Aortic Valve: The UK & Ireland Evolut R Implanters' Registry.
    Kalra SS; Firoozi S; Yeh J; Blackman DJ; Rashid S; Davies S; Moat N; Dalby M; Kabir T; Khogali SS; Anderson RA; Groves PH; Mylotte D; Hildick-Smith D; Rampat R; Kovac J; Gunarathne A; Laborde JC; Brecker SJ
    JACC Cardiovasc Interv; 2017 Feb; 10(3):276-282. PubMed ID: 28183467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of three different new generation transcatheter aortic valve prostheses.
    Costa G; Buccheri S; Barbanti M; Picci A; Todaro D; Di Simone E; La Spina K; D'Arrigo P; Criscione E; Nastasi M; Sgroi C; Tamburino C
    Catheter Cardiovasc Interv; 2020 Feb; 95(3):398-407. PubMed ID: 31609073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the Safety and Effectiveness of Five Leading New-Generation Devices for Transcatheter Aortic Valve Implantation: Twelve-Month Results From the RISPEVA Study.
    Corcione N; Morello A; Ferraro P; Cimmino M; Testa L; Petronio AS; Iadanza A; Bartorelli AL; Berti S; Regazzoli D; Romagnoli E; Spaccarotella C; Tespili M; Pepe M; Frati G; Biondi-Zoccai G; Giordano A;
    J Invasive Cardiol; 2021 May; 33(5):E320-E329. PubMed ID: 33739300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family.
    Möllmann H; Linke A; Holzhey DM; Walther T; Manoharan G; Schäfer U; Heinz-Kuck K; Van Boven AJ; Redwood SR; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Worthley SG
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1538-1547. PubMed ID: 28797431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcathether aortic valve implantation with the new repositionable self-expandable Medtronic Evolut R vs. CoreValve system: evidence on the benefit of a meta-analytical approach.
    Kowalewski M; Gozdek M; Raffa GM; Słomka A; Zieliński K; Kubica J; Anisimowicz L; Kowalewski J; Landes U; Kornowski R; Lorusso R; Suwalski P
    J Cardiovasc Med (Hagerstown); 2019 Apr; 20(4):226-236. PubMed ID: 30829877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative one-month safety and effectiveness of five leading new-generation devices for transcatheter aortic valve implantation.
    Giordano A; Corcione N; Ferraro P; Morello A; Conte S; Testa L; Bedogni F; Iadanza A; Berti S; Regazzoli D; Romagnoli E; Trani C; Burzotta F; Pepe M; Frati G; Biondi-Zoccai G;
    Sci Rep; 2019 Nov; 9(1):17098. PubMed ID: 31745198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the Evolut-R 34 mm versus Sapien-3 29 mm in Transcatheter aortic valve replacement patients with larger annuli: Early outcome results of Evolut-R 34 mm as compared with Sapien-3 29 mm in patients with Annuli ≥26 mm.
    Eitan A; Witt J; Stripling J; Haselbach T; Rieß FC; Schofer J
    Catheter Cardiovasc Interv; 2018 Dec; 92(7):1374-1379. PubMed ID: 29521464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balloon Versus Self-Expandable Valve for the Treatment of Bicuspid Aortic Valve Stenosis: Insights From the BEAT International Collaborative Registrys.
    Mangieri A; Tchetchè D; Kim WK; Pagnesi M; Sinning JM; Landes U; Kornowski R; De Backer O; Nickenig G; Ielasi A; De Biase C; Søndergaard L; De Marco F; Montorfano M; Chiarito M; Regazzoli D; Stefanini G; Presbitero P; Toggweiler S; Tamburino C; Immè S; Tarantini G; Sievert H; Schäfer U; Kempfert J; Wöehrle J; Gallo F; Laricchia A; Latib A; Giannini F; Colombo A
    Circ Cardiovasc Interv; 2020 Jul; 13(7):e008714. PubMed ID: 32646304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procedural and 30-day clinical outcomes following transcatheter aortic valve replacement with lotus valve: Results of the RELEVANT study.
    Montone RA; Testa L; Fraccaro C; Montorfano M; Castriota F; Nerla R; Angelillis M; Tusa M; Giannini F; Garatti A; Tarantini G; Petronio AS; Brambilla N; Bedogni F
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1206-1211. PubMed ID: 28145039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfemoral aortic valve implantation with new-generation devices: the repositionable Lotus vs. the balloon-expandable Edwards Sapien 3 valve.
    Nai Fovino L; Badawy MRA; Fraccaro C; D'Onofrio A; Purita PAM; Frigo AC; Tellaroli P; Mauro A; Tusa M; Napodano M; Gerosa G; Iliceto S; Bedogni F; AbdelRheim AER; Tarantini G
    J Cardiovasc Med (Hagerstown); 2018 Nov; 19(11):655-663. PubMed ID: 30299408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative Matched Outcome of Evolut-R vs CoreValve Transcatheter Aortic Valve Implantation.
    Landes U; Bental T; Barsheshet A; Assali A; Vaknin Assa H; Levi A; Orvin K; Kornowski R
    J Invasive Cardiol; 2017 Feb; 29(2):69-74. PubMed ID: 28145874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes for the Commercial Use of Self-Expanding Prostheses in Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry.
    Sorajja P; Kodali S; Reardon MJ; Szeto WY; Chetcuti SJ; Hermiller J; Chenoweth S; Adams DH; Popma JJ
    JACC Cardiovasc Interv; 2017 Oct; 10(20):2090-2098. PubMed ID: 29050627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective comparison between three TAVR devices: ACURATE neo vs. CoreValve vs. SAPIEN XT. A single heart team experience in patients with severe aortic stenosis.
    Jatene T; Castro-Filho A; Meneguz-Moreno RA; Siqueira DA; Abizaid AAC; Ramos AIO; Arrais M; Le Bihan DCS; Barretto RBM; Moreira AC; Sousa AGMR; Eduardo Sousa J
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):139-146. PubMed ID: 28029207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Direct Comparison of Self-Expandable Portico Versus Balloon-Expandable Sapien 3 Devices for Transcatheter Aortic Valve Replacement: A Case-Matched Cohort Study.
    Mas-Peiro S; Seppelt PC; Weiler H; Mohr GL; Papadopoulos N; Walther T; Zeiher AM; Fichtlscherer S; Vasa-Nicotera M
    J Invasive Cardiol; 2019 Jul; 31(7):E199-E204. PubMed ID: 31257214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Aortic Stenosis With a Self-Expanding, Resheathable Transcatheter Valve: One-Year Results of the International Multicenter Portico Transcatheter Aortic Valve Implantation System Study.
    Linke A; Holzhey D; Möllmann H; Manoharan G; Schäfer U; Frerker C; Worthley SG; van Boven AJ; Redwood S; Kovac J; Butter C; Søndergaard L; Lauten A; Schymik G; Walther T
    Circ Cardiovasc Interv; 2018 Feb; 11(2):e005206. PubMed ID: 29444998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.